Endo (NDOI) Receivables Turnover : 1.11 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Endo's Revenue for the three months ended in Sep. 2024 was $427 Mil. Endo's average Accounts Receivable for the three months ended in Sep. 2024 was $383 Mil. Hence, Endo's Receivables Turnover for the three months ended in Sep. 2024 was 1.11.

Endo Receivables Turnover Historical Data

The historical data trend for Endo's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Receivables Turnover Chart

Endo Annual Data

Trend

Receivables Turnover

Endo Quarterly Data
	Jun23	Sep23	Apr24	Sep24
Receivables Turnover	-	-	-	1.11

Competitive Comparison of Endo's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Endo's Receivables Turnover falls into.

Endo Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Endo's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

	Receivables Turnover (A: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: . 20 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Endo's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Apr. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	426.506	/ (	(0	+	383.225)	/	1 )
=	426.506	/	383.225
=	1.11

Endo (OTCPK:NDOI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Endo Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Endo's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Atwater Drive, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified specialty pharmaceutical company that develops, manufactures, markets and sells a broad portfolio of pharmaceutical products across four reportable segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.